Gastric Volvulus Treatment Market Size Projected To Reach $37.48 Billion By 2034 With A Cagr Of 6.7%

The Gastric Volvulus Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Gastric Volvulus Treatment Market Size and Projected Growth Rate?
In recent times, the market size for treatment of gastric volvulus has seen significant growth. The market is anticipated to expand from a worth of $27.36 billion in 2024 to an estimated $28.95 billion in 2025, progressing at a compound annual growth rate (CAGR) of 5.8%. This expansion in the previous period can be credited to developments in surgical methods, enhancements in diagnostic technologies, increased awareness and education, a surge in minimally invasive procedures, and an uptick in research and clinical studies.

Anticipations are strong for robust expansion in the gastric volvulus treatment market in the coming years. The market is predicted to surge to a valuation of $37.48 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this projected growth can be traced back to regulatory shifts and approvals, surgical procedure innovations, an increasing elderly population, personalized treatment schedules, and the embrace of advanced imaging methods. Foreseen trends over the forecast period involve minimally invasive surgery techniques, increased awareness and early intervention, research into various treatment methods, cooperative medical practices, and tailored treatment strategies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9382

What Are the Different Gastric Volvulus Treatment Market Segments?
The gastric volvulus treatment market covered in this report is segmented -

1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus
2) By Treatment Type: Medication, Surgery
3) By Route Of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:
1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy, Other Treatment Methods
2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques, Other Treatment Approaches

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

What Are the Primary Drivers Shaping the Gastric Volvulus Treatment Market?
The anticipated increase in the elderly population, specifically those aged 65 years and above, is predicted to boost the growth of the gastric volvulus treatment market. Due to reduced immunity and aging, this geriatric group is prone to various ailments, including gastric volvulus, which typically affects individuals over 50 years old. This demographic trend is therefore expected to stimulate the market. For example, the US nonprofit organization, the Population Reference Bureau (PRB), released statistics in January 2024 forecasting a rise in the number of Americans aged 65 and older, from 58 million in 2022 to 82 million in 2050 (an increase of 47%). Their share in the total population is also projected to grow from 17% to 23%. As such, the expanding geriatric populations are catalyzing the advancement of the gastric volvulus treatment market.

Which Companies Are Leading in the Gastric Volvulus Treatment Market?
Major companies operating in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc

What Are the Major Trends Shaping the Gastric Volvulus Treatment Market?
The emergence of product innovations is a rising trend in the gastric volvulus treatment market. To maintain their position in this market, leading firms are focusing on launching inventive products. For instance, Pfizer Inc., a US-based pharmaceutical firm, declared in October 2023 that VELSIPITY (etrasimod), an oral once-daily S1P receptor activator developed for patients with moderate to severe UC, has been approved by the U.S. FDA. VELSIPITY (etrasimod) is recommended with an official dosage of 2mg. This oral once-daily pill, VELSIPITY, gives adults facing moderately to severely active UC an opportunity for steroid-free resolution, displaying a positive benefit-risk profile. The FDA's green light for VELSIPITY signifies a significant juncture for UC patients who need new therapies for their ongoing condition and are prepared to start advanced treatment.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

What Are the Top Revenue-Generating Geographies in the Gastric Volvulus Treatment Market?
North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gastric Volvulus Treatment Market?
2. What is the CAGR expected in the Gastric Volvulus Treatment Market?
3. What Are the Key Innovations Transforming the Gastric Volvulus Treatment Industry?
4. Which Region Is Leading the Gastric Volvulus Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.